SCHEMBL31301263

SCHEMBL31301263

COc1ccc(-n2cnc(C(=O)N(C)c3ccc(Cl)cc3)n2)cc1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GPBAR1 Q8TDU6 5/20 0.47
NOTUM Q6P988 1/20 0.44
MAPT P10636 4/20 0.43
POLB P06746 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.42
TP53 P04637 1/20 0.42
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
HSP90AA1 P07900 2/20 0.40
PDK1 Q15118 1/20 0.40
PDK2 Q15119 1/20 0.40
PDK3 Q15120 1/20 0.40
PDK4 Q16654 1/20 0.40
ALOX5 P09917 1/20 0.40
PTGS2 P35354 1/20 0.40
HPGD P15428 1/20 0.40
MCHR1 Q99705 2/20 0.39
MALT1 Q9UDY8 1/20 0.39
AURKA O14965 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31301336 1.00 GPBAR1 (0.47) GPBAR1NOTUMMAPTPOLBSMN1; SMN2
SCHEMBL31301396 0.94 MAPT (0.46) GPBAR1NOTUMMAPTPOLBSMN1; SMN2
SCHEMBL31301491 0.92 NOTUM (0.44) GPBAR1NOTUMMAPTPOLBSMN1; SMN2
SCHEMBL31301460 0.89 MAPT (0.43) GPBAR1NOTUMMAPTPOLBSMN1; SMN2
SCHEMBL31301359 0.89 MAPT (0.43) GPBAR1NOTUMMAPTPOLBSMN1; SMN2
SCHEMBL31301367 0.89 TP53 (0.41) GPBAR1NOTUMMAPTPOLBSMN1; SMN2
SCHEMBL31301506 0.87 GPBAR1 (0.46) GPBAR1NOTUMMAPTPOLBSMN1; SMN2
SCHEMBL31301487 0.87 GPBAR1 (0.46) GPBAR1NOTUMMAPTPOLBSMN1; SMN2
SCHEMBL31301534 0.86 MCHR1 (0.43) GPBAR1NOTUMMAPTPOLBSMN1; SMN2
SCHEMBL31301379 0.85 LMNA (0.47) GPBAR1NOTUMMAPTPOLBSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4727549-A2 PLASMODIUM FALCIPARUM BLOOD STAGE INHIBITORS University of Georgia Research Foundation, Inc. (US) 2026-04-22 EP disclosed
US-20260097046-A1 PLASMODIUM FALCIPARUM BLOOD STAGE INHIBITORS UNIV GEORGIA (US) 2026-04-09 US disclosed
WO-2024258900-A2 PLASMODIUM FALCIPARUM BLOOD STAGE INHIBITORS UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) 2024-12-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260097046-A1 PLASMODIUM FALCIPARUM BLOOD STAGE INHIBITORS SUB1, PFN1, HCCS GPBAR1 803/4885NOTUM 3845/4885MAPT 4575/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.